ArticleFrontiers in immunology2023

Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review.

Juan Luis Sanz-Cabanillas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.